Exelixis Stock News

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th

Exelixis, Inc. (NASDAQ:EXEL) Director George A. Scangos sold 4,200 shares of the stock in a transaction that occurred on Wednesday, April 22nd. The stock was sold at an average price of $25.05, for a

For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.

During Friday's morning session, 28 stocks hit new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Eli Lilly (...

Eli Lilly (LLY) announces Q1 results. Pfizer (PFE) and Novartis (NVS) provide update on their studies/plans to make coronavirus treatments or vaccines.

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks hitting 52-week highs April 23.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * Chemb

Key clinical trial results this quarter will determine the better buy.

Exelixis, Inc. (NASDAQ:EXEL) – Oppenheimer boosted their FY2021 earnings per share estimates for Exelixis in a research note issued on Monday, April 20th. Oppenheimer analyst S. Tuerkcan now expects

Ballentine Partners LLC grew its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL) by 156.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities

Exelixis, Inc. (NASDAQ:EXEL) – Stock analysts at Piper Sandler issued their Q1 2020 earnings estimates for Exelixis in a research report issued on Monday, April 20th. Piper Sandler analyst E. Tentho

During Thursday's morning trading, these companies set new 52-week highs. Noteworthy Points: Johnson & Johnson (NYSE: JNJ) was the largest company by market cap...

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Johns

Exelixis, Inc. (NASDAQ:EXEL) EVP Patrick J. Haley sold 5,000 shares of Exelixis stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $24.00, for a total value o

Exelixis, Inc. (NASDAQ:EXEL) Director George A. Scangos sold 50,000 shares of the company’s stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $23.

Exelixis, Inc. (NASDAQ:EXEL) – Equities research analysts at Oppenheimer raised their Q1 2020 earnings estimates for shares of Exelixis in a research note issued on Monday, April 20th. Oppenheimer a